pSivida raises $11m in placement for loan repayment

Perth-based biotechnology company pSivida Ltd will raise around $11 million through a placement to pay off a convertible note debt, one day after receiving a promise from collaborative partner Pfizer Inc for a further $6.1 million share purchase.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNiQ Disclaimer